Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMonitise Regulatory News (MONI)

  • There is currently no data for MONI

Director Dealing

11 Apr 2014 15:02

RNS Number : 6818E
Monitise PLC
11 April 2014
 



11 April 2014

 

Monitise plc

 

("Monitise" or the "Company")

 

Director's Dealings

 

Monitise plc (LSE: MONI) announces that it was notified that on 11 April 2014, Peter Ayliffe, Monitise's non-executive chairman, purchased 250,000 ordinary shares of 1p each in the Company at a price of 57.13 pence per ordinary share.

 

Following the transaction, Peter Ayliffe is beneficially interested in 250,000 ordinary shares, representing 0.014 per cent. of the Company's issued share capital.

 

For further information:

 

Monitise plc Tel: 020 3657 0900

Tom Spurgeon, Company Secretary

Andrew Griffin/Haya Herbert-Burns, Investor Relations

 

Canaccord Genuity Limited Tel: 020 7523 8000

Simon Bridges

Cameron Duncan

 

About Monitise

Monitise (LSE: MONI) is a world leader in Mobile Money - banking, paying and buying with a mobile device. Leading banks, payments companies, retailers and mobile networks utilise Monitise's technology platforms and services to securely connect people with their money. 

 

Already 28 million consumers benefit from Monitise's patented technology to 'bank anywhere', 'pay anyone' and 'buy anything', accounting for $71bn of payments, purchases and transfers annually.

More information is available at www.monitise.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGGUUUCUPCGCG
Date   Source Headline
8th Jun 20179:00 amRNSBlock listing Return
1st Jun 20179:00 amRNSTotal Voting Rights
5th May 20174:40 pmRNSSecond Price Monitoring Extn
5th May 20174:35 pmRNSPrice Monitoring Extension
2nd May 20179:00 amRNSTotal Voting Rights
21st Apr 20178:31 amRNSHolding(s) in Company
3rd Apr 20179:00 amRNSTotal Voting Rights
1st Mar 20179:00 amRNSTotal Voting Rights
24th Feb 20177:00 amRNSIssue of Deferred Consideration
23rd Feb 20177:00 amRNSHalf-year Report
1st Feb 20179:22 amRNSTotal Voting Rights
12th Jan 201711:24 amRNSNotice of Results
3rd Jan 201711:56 amRNSStatement re Monitise Americas
3rd Jan 20179:00 amRNSTotal Voting Rights
30th Dec 201612:35 pmRNSPrice Monitoring Extension
28th Dec 20169:59 amRNSBlock listing Return
8th Dec 20169:00 amRNSBlock listing Return
1st Dec 20168:59 amRNSTotal Voting Rights
24th Nov 20164:35 pmRNSPrice Monitoring Extension
1st Nov 20169:39 amRNSTotal Voting Rights
19th Oct 20161:09 pmRNSResult of AGM
14th Oct 20163:46 pmRNSHolding(s) in Company
3rd Oct 20169:00 amRNSTotal Voting Rights
20th Sep 20169:00 amRNSAnnual Report & Accounts and Notice of AGM
8th Sep 20167:00 amRNSFY 2016 Results
7th Sep 20164:53 pmRNSChange of Registered Office
1st Sep 20166:24 pmRNSTotal Voting Rights
21st Jul 20167:00 amRNSTrading Update
7th Jul 20164:38 pmRNSHolding(s) in Company
7th Jul 20161:07 pmRNSIssue of Deferred Consideration
1st Jul 20164:45 pmRNSTotal Voting Rights
30th Jun 20166:25 pmRNSDirectorate Change
27th Jun 20169:00 amRNSBlock Listing Return
24th Jun 201612:08 pmRNSSecond Price Monitoring Extn
24th Jun 201612:02 pmRNSPrice Monitoring Extension
16th Jun 201612:07 pmRNSSecond Price Monitoring Extn
16th Jun 201612:02 pmRNSPrice Monitoring Extension
15th Jun 201612:07 pmRNSSecond Price Monitoring Extn
15th Jun 201612:02 pmRNSPrice Monitoring Extension
14th Jun 201612:07 pmRNSSecond Price Monitoring Extn
14th Jun 201612:02 pmRNSPrice Monitoring Extension
8th Jun 20169:00 amRNSBlock Listing Return
1st Jun 20164:40 pmRNSSecond Price Monitoring Extn
1st Jun 20164:35 pmRNSPrice Monitoring Extension
1st Jun 20169:00 amRNSTotal Voting Rights
31st May 20167:00 amRNSStatement re Monitise Content
3rd May 20169:00 amRNSTotal Voting Rights
1st Apr 20169:00 amRNSTotal Voting Rights
29th Mar 20167:00 amRNSAppointment of COO
17th Mar 20164:13 pmRNSIssue of earn-out consideration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.